SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AdaptHealth Q3 Revenue Comes in at $745.648 Million

AdaptHealth reported Q3 revenue of $745.648 million, versus an IBES estimate of $746.4 million.

AHCO
SquawkNews Desk 1 updates Updated Nov 03, 2026, 12:32 PM UTC

Story updates

12:32:08 PM UTC
SquawkNews
*-- Earnings Flash (AHCO) AdaptHealth Posts Q3 Revenue $745.6M, vs. FactSet Est of $725.9M

Related stories

Pfizer Reports Q3 Revenue of $16.6 Billion, Raises 2026 Guidance Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year operationally, and adjusted diluted EPS of $0.87. It raised full-year revenue guidance t M impact | EQUITY | Nov 03, 2026, 01:22 PM UTC CACI Wins Five-Year, $108 Million U.S. Air Force Contract CACI said it was awarded a five-year, $108 million contract by the U.S. Air Force to advance financial transparency, operational efficiency and mission readiness. M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC Rankin Acquires 41,350 Shares Outside the Marketplace Rankin acquired 41,350 shares at SEK 235.15 on Nov. 3, 2026, outside the marketplace. M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC Petrobras shares fall more than 3% in early trading M impact | EQUITY | Nov 03, 2026, 01:15 PM UTC Teva Q3 Revenue Falls 2% to $4.4 Billion, Raises 2026 Brand Outlook Teva reported third-quarter 2026 revenue of $4.395 billion, down 2% year over year. Gross margin was 55.5%, net income attributable to Teva was $233 million and adjusted diluted EP M impact | EQUITY | Nov 03, 2026, 01:15 PM UTC Chegg Q3 Revenue Falls as Legacy Business Declines M impact | EQUITY | Nov 03, 2026, 01:15 PM UTC